Ambu 将来の成長

Future 基準チェック /46

Ambu利益と収益がそれぞれ年間28.1%と11.4%増加すると予測されています。EPS は年間増加すると予想されています。自己資本利益率は 3 年後に15.2% 32.6%なると予測されています。

主要情報

28.1%

収益成長率

32.6%

EPS成長率

Medical Equipment 収益成長	22.6%
収益成長率	11.4%
将来の株主資本利益率	15.2%
アナリストカバレッジ	Good
最終更新日	15 Nov 2024

今後の成長に関する最新情報

Recent updates

業績と収益の成長予測

BATS-CHIXE:AMBUBC - アナリストの将来予測と過去の財務データ ( )DKK Millions
日付	収益	収益	フリー・キャッシュフロー	営業活動によるキャッシュ	平均アナリスト数
9/30/2027	7,615	1,058	883	1,333	4
9/30/2026	6,771	816	643	1,046	6
9/30/2025	6,039	638	466	839	6
9/30/2024	5,391	235	524	813	N/A
6/30/2024	5,263	450	614	893	N/A
3/31/2024	5,075	367	608	902	N/A
12/31/2023	4,897	238	501	805	N/A
9/30/2023	4,775	168	192	518	N/A
6/30/2023	4,679	-42	-168	217	N/A
3/31/2023	4,612	-65	-318	119	N/A
12/31/2022	4,545	95	-475	25	N/A
9/30/2022	4,444	93	-463	95	N/A
6/30/2022	4,307	222	-401	185	N/A
3/31/2022	4,152	256	-521	107	N/A
12/31/2021	4,031	176	-419	194	N/A
9/30/2021	4,013	247	-256	328	N/A
6/30/2021	3,858	251	-187	347	N/A
3/31/2021	3,832	281	111	593	N/A
12/31/2020	3,820	290	56	511	N/A
9/30/2020	3,567	241	-135	295	N/A
6/30/2020	3,302	146	-24	366	N/A
3/31/2020	3,128	270	-62	277	N/A
12/31/2019	2,924	296	37	330	N/A
9/30/2019	2,820	317	272	533	N/A
6/30/2019	2,943	515	361	597	N/A
3/31/2019	2,843	411	316	553	N/A
12/31/2018	2,709	372	327	560	N/A
9/30/2018	2,606	337	318	554	N/A
6/30/2018	2,506	318	N/A	498	N/A
3/31/2018	2,434	288	N/A	456	N/A
12/31/2017	2,396	281	N/A	476	N/A
9/30/2017	2,355	301	N/A	462	N/A
6/30/2017	2,299	306	N/A	403	N/A
3/31/2017	2,215	299	N/A	460	N/A
12/31/2016	2,134	267	N/A	420	N/A
9/30/2016	2,084	250	N/A	369	N/A
6/30/2016	2,047	224	N/A	408	N/A
3/31/2016	2,012	169	N/A	269	N/A
12/31/2015	1,963	175	N/A	246	N/A
9/30/2015	1,889	152	N/A	208	N/A
6/30/2015	1,795	171	N/A	141	N/A
3/31/2015	1,710	184	N/A	137	N/A
12/31/2014	1,630	156	N/A	147	N/A
9/30/2014	1,584	151	N/A	183	N/A
6/30/2014	1,543	94	N/A	167	N/A
3/31/2014	1,524	67	N/A	141	N/A
12/31/2013	1,456	40	N/A	148	N/A

アナリストによる今後の成長予測

収入対貯蓄率: AMBUBCの予測収益成長率 (年間28.1% ) は貯蓄率 ( 2.1% ) を上回っています。

収益対市場: AMBUBCの収益 ( 28.1% ) はUK市場 ( 14.7% ) よりも速いペースで成長すると予測されています。

高成長収益: AMBUBCの収益は今後 3 年間で大幅に増加すると予想されています。

収益対市場: AMBUBCの収益 ( 11.4% ) UK市場 ( 3.5% ) よりも速いペースで成長すると予測されています。

高い収益成長: AMBUBCの収益 ( 11.4% ) 20%よりも低い成長が予測されています。

一株当たり利益成長率予想

将来の株主資本利益率

将来のROE: AMBUBCの自己資本利益率は、3年後には低くなると予測されています ( 15.2 %)。

Ambu 将来の成長

Future 基準チェック /46

主要情報

今後の成長に関する最新情報

Ambu A/S Maintains Earnings Guidance for the Full-Year 2023/24

Ambu A/S Provides Earnings Guidance for the Full-Year 2023/24

Ambu A/S Narrows Earnings Guidance for the Full-Year 2022/23

Ambu A/S Raises Earnings Guidance for the Full-Year 2022/2023

Ambu A/S Raises Earnings Guidance for the Full-Year 2022/2023

Ambu A/S Provides Earnings Guidance for the Financial Year of 2022-2023

Recent updates

Ambu A/S Proposes Dividend

Ambu A/S, Annual General Meeting, Dec 03, 2025

Ambu A/S to Report Q1, 2025 Results on Jan 30, 2025

Second quarter 2024 earnings released: EPS: kr.0.54 (vs kr.0.06 in 2Q 2023)

First quarter 2024 earnings released: EPS: kr.0.35 (vs kr.0.09 in 1Q 2023)

Ambu A/S Maintains Earnings Guidance for the Full-Year 2023/24

Ambu A/S Elects Shacey Petrovic as Vice Chair of Board of Directors

High number of new directors

Ambu A/S Announces Henrik Ehlers Wulff Not to Run for Re-Election for Board of Directors

Ambu A/S Provides Earnings Guidance for the Full-Year 2023/24

Ambu A/S Appoints Henrik Skak Bender as Member of the Executive Management, Effective 1 January 2024

Ambu A/S Announces Chief Financial Officer Changes

Ambu A/S to Report Q2, 2024 Results on May 14, 2024

Ambu A/S Narrows Earnings Guidance for the Full-Year 2022/23

Third quarter 2023 earnings released

High number of new directors

Ambu A/S Raises Earnings Guidance for the Full-Year 2022/2023

Ambu A/S Raises Earnings Guidance for the Full-Year 2022/2023

High number of new directors

Second quarter 2023 earnings released

High number of new directors

High number of new directors

First quarter 2023 earnings released: EPS: kr.0.09 (vs kr.0.08 in 1Q 2022)

High number of new directors

Ambu A/S Provides Earnings Guidance for the Financial Year of 2022-2023

High number of new directors

High number of new directors

Ambu A/S Provides Earnings Guidance for the Financial Year of 2022-2023

Full year 2022 earnings released

Ambu A/S to Report Q3, 2023 Results on Aug 31, 2023

Less than half of directors are independent

Ambu A/S(CPSE:AMBU B) dropped from FTSE All-World Index (USD)

Less than half of directors are independent

Ambu A/S Reaffirms Earnings Guidance for the Full-Year 2021/2022

Ambu A/S Revises Earnings Guidance for the Full-Year 2021/2022

Ambu Announces FDA Clearance of Fifth-Generation Single-Use Bronchoscope

Less than half of directors are independent

Ambu A/S Reaffirms Earnings Guidance for the Fiscal Year 2021/22

Second quarter 2022 earnings released

Less than half of directors are independent

First quarter 2022 earnings: Revenues and EPS in line with analyst expectations

Ambu A/S Revises Revenue Guidance for the Fiscal 2022

Ambu Announces FDA Clearance of Single-Use Gastroscope and Next-Generation Display Unit

Upcoming dividend of kr.0.29 per share

Full year 2021 earnings released: EPS kr.0.98 (vs kr.0.98 in FY 2020)

Third quarter 2021 earnings released

Less than half of directors are independent

Ambu A/S Revises Revenue Guidance for the Fiscal 2021

Second quarter 2021 earnings released

Ambu A/S Reaffirms Earnings Guidance for the Fiscal Year 2021

New 90-day high: kr.331

Ambu A/S has completed a Follow-on Equity Offering in the amount of DKK 1.2345 billion.

Revenue beats expectations

New 90-day high: kr.310

First quarter 2021 earnings released

Ambu A/S to Report Fiscal Year 2021 Results on Nov 09, 2021

New 90-day high: kr.263

New 90-day high: kr.212

Upcoming Dividend of kr.0.29 Per Share

Ambu A/S Announces Board Changes

Ambu A/S to Report Q2, 2021 Results on May 12, 2021

業績と収益の成長予測

アナリストによる今後の成長予測

一株当たり利益成長率予想

将来の株主資本利益率

成長企業の発掘